Bristol Myers Squibb Co., based in Princeton, NJ, employs 34,100 staff and develops biopharmaceuticals across various therapeutic classes, including oncology and immunology. Key products include Eliquis and Opdivo, with a strong pipeline featuring Krazati and KarXT.
BristolMyers Squibb Company (BMY) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, BristolMyers Squibb Company's actual EPS was $1.80, beating the estimate of $1.51 per share, resulting in a 19.36% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
